Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

ECO 2026 12 - 15 May 2026

Zenagamtide, a Novel, Long-Acting, Unimolecular GLP-1 and Amylin Receptor Agonist, Does Not Impact the Pharmacokinetics of the Combined Oral Contraceptive, Levonorgestrel/Ethinylestradiol

Authors :

Maria B. N. Gabe¹;Ruben Duque do Vale¹; Swathi Gopal¹; Tobias Karlsson¹;Gaetano Morelli²; Anne Flint¹

Affiliations

View Details Hide Details

Download .PDF

Keywords

Congress poster

GLP-1 RA

Amylin

Pre-clinical